PMID: 20127549Feb 4, 2010Paper

American Society of Hematology--51st annual meeting & exposition. Part 1

IDrugs : the Investigational Drugs Journal
Jaya Shumoogam, Natasher Beecher

Abstract

The 51st American Society of Hematology (ASH) Annual Meeting and Exposition, held in New Orleans, included topics covering new therapeutic developments in the field of hematology. This conference report highlights selected presentations on hematological malignancies, lymphoma, Hodgkin lymphoma, AKT inhibitors for the treatment of chronic lymphocytic leukemia, and the activation of GPIb with von Willebrand factor. Investigational drugs discussed include conatumumab (Amgen Inc/Takeda Bio Development Center Ltd) and A-443654 (Abbott Laboratories).

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Related Papers

IDrugs : the Investigational Drugs Journal
Jaya Shumoogam, Natasher Beecher
Clinical Advances in Hematology & Oncology : H&O
IDrugs : the Investigational Drugs Journal
Matthew C Catley
© 2021 Meta ULC. All rights reserved